Cheng TC, Huang BM, Liao YC, Chang HS, et al. Fibroblast growth factor receptor four inhibitor FGF401 improves the efficacy of trastuzumab in FGFR4-overexpressing breast cancer cells. Int J Cancer 2024 Dec 16. doi: 10.1002/ijc.35271.
PMID: 39679940